首页> 外文会议>11th Regional Western Pacific Congress of International Society of Blood Transfusion Nov, 2001 Shanghai >Artificial blood― RBC Substitute: Research development and clinical trials
【24h】

Artificial blood― RBC Substitute: Research development and clinical trials

机译:人造血― RBC替代品:研究与开发及临床试验

获取原文
获取原文并翻译 | 示例

摘要

Blood transfusion is in indispensable means in the modern clinic. However, complex irnmunologic response is involved in the process; and transfusion-associated transmissible diseases constitute great concern to the recipients; Besides , the strict condition under which blood is stored and transported is a limit to transfusion in Casualty and battle salvation. Thus, research and development of ideal artificial blood―RBC and platelet substitute has been a long-persuited major subject. This reviewing more than 300 references cited in 5 books on RBC substites, and covering the achievements in the basic research, the large-scale production and the clinical trials in the past 70 years, gives and outline of the characteristic , accomplishment, difficulty and research foucus of various preparations, in order to have a brief description of the status of RBC substitutes.
机译:输血是现代诊所必不可少的手段。但是,该过程涉及复杂的免疫反应。与输血有关的传染性疾病引起了接收者的极大关注;此外,血液储存和运输的严格条件限制了伤亡和救赎中的输血。因此,理想的人造血RBC和血小板替代品的研究和开发一直是一个长期的课题。本文回顾了5本书中有关RBC替代物的300多篇参考文献,涵盖了基础研究,大规模生产和临床试验在过去70年中取得的成就,并概述了其特征,成就,难度和研究重点讨论各种准备工作,以便简要介绍RBC替代品的状况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号